Highly expressed in neural tissues, GSK-3β has been implicated in several neurological disorders, including Alzheimer’s disease (AD), Parkinson’s disease (PD), and schizophrenia [11], [12], [13]. This evidence concerns the gene GSK3B and schizophrenia.